Rhapontin
Rhapontin (Rhaponiticin) is an orally aactive SIRT1 agonist and AMPK activator with anti-inflammatory and anti-fibrotic activities. Rhapontin inhibits NLRP3 inflammasome activation by activating SIRT1 and inhibits TGF-β/Smad signaling via the AMPK pathway. Rhapontin reduces intestinal and lung inflammation, inhibits fibroblast differentiation and extracellular matrix deposition, and enhances tight junction protein expression to repair epithelial barriers. Rhapontin can be used in the study of inflammatory bowel diseases (such as ulcerative colitis) and pulmonary fibrosis[1][2][3].
Product Specifications
CAS Number
[155-58-8]
Product Name Alternative
Rhaponiticin
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis
Type
Natural Products
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer; Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/rhapontin.html
Concentration
10mM
Purity
99.73
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O[C@H]([C@@H](O)[C@@H]1O)[C@@H](O[C@@H]1CO)OC2=CC(/C=C/C3=CC(O)=C(OC)C=C3)=CC(O)=C2
Molecular Formula
C21H24O9
Molecular Weight
420.41
Precautions
H302, H315, H319, H335
References & Citations
Rheum officinale Baillon
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CRYBB2 (Crystallin, beta B2, CCA2, CRYB2, CRYB2A, D22S665) (MaxLight 650)
CRYBB2 (Crystallin, beta B2, CCA2, CRYB2, CRYB2A, D22S665) (MaxLight 650)
Prostacyclin Synthase, NT (Prostaglandin I2 Synthase, CYP8A1, PTGIS, CYP8, CYP8A1)